Skip to main content

Psychosexual Therapy

Psychosexual therapy is the canonical WARWIKI page for the cross-cutting psychological and behavioral interventions used to treat sexual dysfunction in both men and women — sensate focus, cognitive behavioral therapy (CBT), mindfulness-based interventions (MBI), the PLISSIT counseling model, sex education and skills training, and couples / interpersonal therapy. The framework is grounded in Masters and Johnson and integrated within the contemporary biopsychosocial model of sexual dysfunction.[1][2][3] It is recommended by AUA 2018 (ED), AUA / SMSNA 2022 (PE), ACOG PB 213 (FSD), and ESSM as first-line or adjunctive treatment across many sexual-dysfunction phenotypes.[4][5][6]

This page is referenced as the canonical link target from the erectile-dysfunction and Peyronie's-disease databases (04j), the female sexual dysfunction page (Women's Health), and the small-penis-syndrome / PDD clinical-conditions page.

Foundations and core techniques​

Psychosexual therapy is grounded in the principle that sexual dysfunction arises from a complex interplay of biological, psychological, and sociocultural factors.[1][7]

TechniqueCore ideaKey uses
Sensate focus (Masters & Johnson)Structured exercises beginning with non-sexual physical touch progressing gradually to sexual touch; partners alternate touching and feedback. Reduces performance anxiety; shifts focus from goal-oriented to pleasure-oriented intimacy.ED, FSIAD, dyspareunia, post-trauma reconnection[8][9]
Cognitive behavioral therapy (CBT)Targets maladaptive thoughts, unreasonable expectations, cognitive distortions (e.g., self-monitoring during sex), and negative attitudes about sexuality. Helps build healthier sexual scripts and reduce anxiety.FSIAD, female orgasmic disorder, GPPPD, ED[8][10]
Mindfulness-based interventions (MBI)Present-moment, non-judgmental attention; reduces sexual distress and avoidance. Ranked first for sexual distress in the 2026 network meta-analysis of 45 studies / 4,726 women.FSIAD (especially with distress); breast-cancer-survivor sexual concerns; relapse prevention[11]
PLISSIT modelStepped-care framework: Permission → Limited Information → Specific Suggestions → Intensive Therapy. Ranked first for overall FSFI improvement in the same 2026 NMA.First-tier office counseling that any clinician can deliver before referral.[11]
Sex education and sexual skills trainingAnatomy, physiology, masturbation techniques, communication. Includes directed masturbation for orgasmic disorder.Female orgasmic disorder; men with limited sexual literacy; couples seeking partner-directed skill building[3][4]
Couples / interpersonal therapyRelationship dynamics, emotional intimacy, communication, partner-related contributors to dysfunction.Distress that is interpersonally driven; ED with partner concerns; FSIAD[7][8]

Indications in women​

Psychosexual therapy is recommended for the major DSM-5 / ICSM female sexual dysfunction phenotypes:[4][5][7]

PhenotypeEvidence
Female sexual interest / arousal disorder (FSIAD)CBT, MBI, couples therapy, and sexual skills training all supported. Two RCTs of group CBT specifically for FSIAD; combined CBT / sex therapy: 74% improved sexual and marital satisfaction; 64% maintained at 1 year.[5][8]
Female orgasmic disorderSexual skills training (including directed masturbation) is the primary treatment. Education about clitoral stimulation, body awareness, addressing guilt / shame. For trauma-related orgasmic disorder, a trauma-informed psychotherapeutic approach is recommended.[4][12]
Genito-pelvic pain / penetration disorder (vaginismus, dyspareunia)Pelvic floor PT is first-line. Psychosexual therapy using systematic desensitization, graded vaginal dilators, relaxation, and CBT is integral.[5][9]

A meta-analysis of 20 RCTs found pooled post-treatment effect sizes of d = 0.58 for symptom severity and d = 0.47 for sexual satisfaction, with the strongest evidence for hypoactive sexual desire disorder and orgasmic disorder.[13]

Indications in men​

PhenotypeEvidence
Erectile dysfunction (psychogenic component or adjunct)Cochrane 2007 (Melnik): pooled group psychotherapy reduced persistence of ED vs waitlist (RR 0.40; 95% CI 0.17–0.98), maintained at 6 mo. Group therapy + sildenafil > sildenafil alone (RR 0.46 for persistence); a small trial found group therapy alone superior to sildenafil on IIEF.[14] AUA 2018: Moderate (Grade C).
Premature ejaculation (PE)AUA / SMSNA 2022: Moderate Recommendation (Grade C) for referral to a mental-health professional with sexual-health expertise. Behavioral techniques (stop-start, squeeze) effective; integrated psychotherapy may be useful even when no clear psychological etiology is apparent.[6][15]
Combined approachA 20-controlled-trial SR of male sexual dysfunction interventions (Berner & Günzler 2012): most Masters-and-Johnson- or CBT-derived interventions improved sexual functioning, but methodological quality was generally low. Long-term studies suggest stable improvement in sexual satisfaction, though symptom reduction may be less durable — supporting the addition of relapse-prevention strategies.[15][3]

Combined therapy — psychosexual + pharmacologic​

Across both sexes, combination therapy generally outperforms either alone:[7][14]

  • ED: group therapy + sildenafil reduced persistence of dysfunction more than sildenafil alone, with lower dropout.[14]
  • Female sexual dysfunction: pharmacologic options (flibanserin, bremelanotide, vaginal estrogen, vaginal DHEA, transdermal testosterone) show modest benefits and are best used alongside psychological interventions.[5][1]
  • Mixed organic + psychogenic etiology — common in older men and women with dyspareunia — requires both psychotherapy and medical treatment.[3]

Comparative effectiveness (women) — Qiangzhao 2026 network meta-analysis​

InterventionBest forRanking
PLISSIT modelImproving overall sexual function (FSFI)1st for function
CBTFunction and distress reduction2nd for function; 3rd for distress
General sexual counselingImproving sexual function3rd for function
Mindfulness-based interventionsReducing sexual distress (FSDS)1st for distress
Sex educationBroad improvement5th for function; 2nd for distress

(Network meta-analysis of 45 studies, 4,726 women.[11])

Practical considerations​

  • Format. Individual, couple, group, or online (telehealth has expanded post-COVID access). Sessions vary in number; include both partners when possible.[6][8]
  • Referral. ACOG recommends consultation with or referral to mental health specialists with sexual-health expertise — sex therapists (AASECT-certified), psychologists, psychiatrists, or marriage / couples counselors — calibrated to the clinician's own expertise.[4]
  • Format-dose framework. Individual / couple / group format choice should be matched to the dominant contributor (intrapsychic vs interpersonal vs psychoeducational).
  • Limitations. Evidence base supportive but limited by small sample sizes, heterogeneous populations, variable outcome measures, and generally low methodological quality of trials.[15][16][8][1]
  • Durability. Long-term studies indicate that improvements in sexual satisfaction tend to be more stable than reductions in specific sexual symptoms — incorporate relapse-prevention strategies.[3]

When psychosexual therapy is the highest-yield intervention​

  • Primary psychogenic ED with negligible organic component, or ED dominated by performance anxiety in younger men.[2][14]
  • PE with significant interpersonal distress, especially when SSRIs are declined or contraindicated.[6][15]
  • FSIAD with high distress (MBI ranked first by NMA).[11]
  • Female orgasmic disorder (sexual skills training is the canonical treatment).[4]
  • Vaginismus / GPPPD as integral adjunct to PFPT and graded dilators.[5][9]
  • SPS / PDD — body-image and dysmorphic distress in men with objectively normal anatomy. Pre-procedural counseling is the first-line intervention; psychosexual therapy and BDD screening should precede any cosmetic procedure.[17]
  • Post-trauma sexual recovery — trauma-informed sex therapy.[12]
  • Mixed organic + psychogenic dysfunction — combine with pharmacologic / mechanical treatment.[3][14]

See Also​

References​

1. Davis SR. Sexual dysfunction in women. N Engl J Med. 2024;391(8):736–745. doi:10.1056/NEJMcp2313307

2. Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153–165. doi:10.1016/S0140-6736(12)60520-0

3. Kockott G. Psychotherapy for sexual dysfunctions and desire disorders. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(1):11–18. doi:10.1007/s00103-007-0112-2

4. Committee on Practice Bulletins—Gynecology, American College of Obstetricians and Gynecologists. Female sexual dysfunction: ACOG Practice Bulletin No. 213. Obstet Gynecol. 2019;134(1):e1–e18. doi:10.1097/AOG.0000000000003324

5. Dalrymple SN, Hoeg L, Thacker H. Female sexual dysfunction: common questions and answers. Am Fam Physician. 2025;111(5):433–442.

6. Shindel AW, Althof SE, Carrier S, et al. Disorders of ejaculation: an AUA / SMSNA guideline. J Urol. 2022;207(3):504–512. doi:10.1097/JU.0000000000002392

7. Brotto L, Atallah S, Johnson-Agbakwu C, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2016;13(4):538–571. doi:10.1016/j.jsxm.2016.01.019

8. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354(14):1497–1506. doi:10.1056/NEJMcp050154

9. Melnik T, Hawton K, McGuire H. Interventions for vaginismus. Cochrane Database Syst Rev. 2012;12:CD001760. doi:10.1002/14651858.CD001760.pub2

10. Melnik T, Althof S, Atallah AN, et al. Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev. 2011;(8):CD008195. doi:10.1002/14651858.CD008195.pub2

11. Qiangzhao L, Qiong L, Bohong G, et al. Psychological therapies for female sexual function: a systematic review and network meta-analysis. J Sex Med. 2026;23(3):qdag040. doi:10.1093/jsxmed/qdag040

12. Almås E, Benestad EEP. Treatment of traumatised sexuality. Front Psychol. 2021;12:610619. doi:10.3389/fpsyg.2021.610619

13. Frühauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013;42(6):915–933. doi:10.1007/s10508-012-0062-0

14. Melnik T, Soares BG, Nasselo AG. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev. 2007;(3):CD004825. doi:10.1002/14651858.CD004825.pub2

15. Berner M, Günzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions — Part 1: male sexual dysfunction. J Sex Med. 2012;9(12):3089–3107. doi:10.1111/j.1743-6109.2012.02970.x

16. Günzler C, Berner MM. Efficacy of psychosocial interventions in men and women with sexual dysfunctions — Part 2: female sexual dysfunction. J Sex Med. 2012;9(12):3108–3125. doi:10.1111/j.1743-6109.2012.02965.x

17. Trost L, Mulhall JP, Stember DS, et al. SMSNA position statement on penile augmentation. Sex Med Rev. 2024;12(3):331–340. doi:10.1093/sxmrev/qeae018